Otsuka Pakistan Limited
PPSX:OTSU374.63
PKR
+4.63
(+1.25%)
Otsuka Pakistan Limited
PSX:OTSU
(Pakistan Stock Exchange)
Recent
price
374.63
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Otsuka Pakistan Limited is a Pakistan-based healthcare and pharmaceutical company primarily engaged in the manufacturing, marketing, and distribution of intravenous infusions, clinical nutrition products, and medical devices. Incorporated in 1988 and headquartered in Karachi, Pakistan, the company operates as a subsidiary of Otsuka Pharmaceutical Co., Ltd., which is part of Japan-based Otsuka Holdings Co., Ltd. The company maintains its primary manufacturing facility at the Hub Industrial Trading Estate in Balochistan, supplying government healthcare institutions, private hospitals, clinical laboratories, and retail pharmacies across Pakistan, while also serving select export destinations in South Asia, the Middle East, and Africa. The company's core operations are organized into three primary product segments: Intravenous (IV) Infusion Solutions, comprising large-volume and small-volume parenterals, dextrose solutions, sodium chloride solutions, Ringer's lactate, pediatric maintenance solutions, and ready-to-infuse therapeutic formulations including antibiotics; Clinical Nutrition and Specialized Formulations, consisting of enteral nutrition supplements, amino acid infusions, oral rehydration salts, and therapeutic electrolyte management solutions; and Medical Devices and Disposables, featuring hemodialysis solutions, peritoneal dialysis systems, blood tubing lines, arteriovenous (AV) fistula needles, intravenous cannulas, and infusion administration sets. In recent developments, Otsuka Pakistan Limited has executed multiple operational enhancements and capacity expansion projects to strengthen domestic supply continuity and operational resilience. The company upgraded its blow-fill-seal (BFS) production and automated inspection lines at its Hub manufacturing plant to increase output capacity for sterile liquid injectables and parenterals. To mitigate escalating energy costs and reduce its carbon footprint, the company implemented an industrial-scale solar power generation system at its manufacturing site. Furthermore, Otsuka Pakistan has expanded its commercial medical device offerings, broadened domestic distribution channels across secondary and tertiary care centers, and pursued import-substitution initiatives for critical manufacturing inputs to counteract foreign currency volatility.